REFERENCES
- Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166–178
- Winick NJ, Carroll WL, Hunger SP. Childhood leukemia: new advances and challenges. N Engl J Med 2004; 351: 601–603
- Bow EJ, Kilpatrick MG, Clinch JJ. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 1999; 17: 1267–1273
- Carr E, Jayabose S, Stringel G, et al. The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2006; 47: 886–888
- Krzywda EA, Andris DA. Twenty-five years of advances in vascular access: Bridging research to clinical practice. Nutr Clin Pract 2005; 20: 597–606
- McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005; 23: 3024–3029
- Nouwen JL, Wielenga JJ, van Overhagen H, et al. Hickman catheter-related infections in neutropenic patients: Insertion in the operating theater versus insertion in the radiology suite. J Clin Oncol 1999; 17: 1304–1311
- Nosher JL, Bodner LJ, Ettinger LJ, et al. Radiologic placement of a low profile implantable venous access port in a pediatric population. Cardiovasc Intervent Radiol 2001; 24: 395–399
- Lorenz JM, Funaki B, Van Ha T, et al. Radiologic placement of implantable chest ports in pediatric patients. AJR Am J Roentgenol 2001; 176: 991–994
- Flynn PM, Willis B, Gaur AH, et al. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 2003; 21: 3520–3525
- Bodner LJ, Nosher JL, Patel KM, et al. Peripheral venous access ports: Outcomes analysis in 109 patients. Cardiovasc Intervent Radiol 2000; 23: 187–193
- Munro FD, Gillett PM, Wratten JC, et al. Totally implantable central venous access devices for paediatric oncology patients. Med Pediatr Oncol. 1999; 33: 377–381
- Biffi R, Corrado F, de Braud F, et al. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of device. Eur J Cancer 1997; 33: 1190–1194
- Kock HJ, Pietsch M, Krause U, et al. Implantable vascular access systems: Experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998; 22: 12–16
- Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006; 62: 358–365
- Babu R, Spicer RD. Implanted vascular access devices (ports) in children: Complications and their prevention. Pediatr Surg Int. 2002; 18: 50–53
- Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003; 21: 3665–3675